搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
5 小时
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...
8 小时
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in ...
Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...
Craig Daily Press
5 天
In-town treatment for substance-use disorder helps Craig residents recover
A mom of three young children, Craig resident Tanisha Young, 29, recently lost her dad, and in past times in her life, that ...
Frontiers
5 天
Neuro-Immune Crosstalk in Peripheral Neuropathy: From Mechanisms to Therapeutic Opportunities
Peripheral neuropathy encompasses a variety of conditions marked by damage or lesions to peripheral nerves, resulting in symptoms such as pain, itch, and sensory disturbances. Diseases such as ...
Pharmaceutical Technology
6 天
EU CHMP recommends AstraZeneca and Ionis’ Wainzua for ATTRv-PN
The European Union's CHMP has recommended the approval of AstraZeneca and Ionis Pharmaceuticals’ Wainzua to treat ATTRv-PN.
6 天
Coronation Street star faces fresh health fears as team rally around her after diagnosis
EXCLUSIVE: The former Coronation Street star has recruited help for her new role away from soap life, in fear of not being ...
pharmaphorum
6 天
AZ, Ionis get CHMP backing for ATTR polyneuropathy drug
AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...
EuropaWire
7 天
Wainzua Receives EU Recommendation for Treating Hereditary Amyloidosis, Offering New ...
AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...
India Education Diary
7 天
Birmingham Researchers Awarded 2024 Glaucoma UK Research Grant for Novel Treatment Development
Researchers from the University of Birmingham have been announced as winners of the 2024 Glaucoma UK and Royal College of ...
7 天
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈